Calendar TransCode Therapeutics, Inc.

Equities

RNAZ

US89357L3033

Market Closed - Nasdaq 16:30:00 2024-04-26 EDT 5-day change 1st Jan Change
0.5499 USD +4.74% Intraday chart for TransCode Therapeutics, Inc. +13.38% -91.66%

Chart calendar TransCode Therapeutics, Inc.

d158c1cc61d84735d184c5b7.l4SEREUy4CIGa4BoAb_Be1cK2Jn6UbMsbSD6pEzUO1Y.pbDHKhVx1G1qWrhbT8yyIxphtva9GfZKAxiD0yWzSg70_tF3MVXSSkQ76w~f927e3d9af87467934aafe046b6b4081

Upcoming events on TransCode Therapeutics, Inc.

2024-05-12 Q1 2024 Earnings Release (Projected)
2024-08-11 Q2 2024 Earnings Release (Projected)
2024-11-10 Q3 2024 Earnings Release (Projected)
2025-03-27 Q4 2024 Earnings Release (Projected)

Past events on TransCode Therapeutics, Inc.

2024-04-03 09:10 Q4 2023 Earnings Release
2024-03-14 09:10 RNA Leaders Europe Congress
2024-01-08 09:00 Extraordinary Shareholders Meeting
2023-12-04 San Antonio Breast Cancer Symposium
2023-11-14 16:30 Q3 2023 Earnings Release
2023-10-19 13:30 ThinkEquity Conference
2023-09-11 H.C. Wainwright Global Investment Conference
2023-08-14 16:45 Q2 2023 Earnings Release
2023-05-09 Annual General Meeting
2023-04-13 American Association for Cancer Research Meeting
2023-03-31 16:01 Q4 2022 Earnings Release
2022-11-14 16:15 Q3 2022 Earnings Release
2022-11-09 14:30 Sidoti Micro Cap Virtual Conference
2022-10-26 14:30 ThinkEquity Conference
2022-10-03 13:00 Chardan Genetic Medicines Conference
2022-08-15 16:15 Interim 2022 Earnings Release
2022-06-22 11:00 Annual General Meeting
2022-06-13 17:30 BIO International Convention
2022-05-24 07:00 H.C. Wainwright Global Life Sciences Investment Conference
2022-05-16 08:30 Q1 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-6,15
-6,07
-1.42%
-18,7
-18,7
0.18%
-19,4
-21,1
7.97%

-14,7

Earnings before Tax (EBT)
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

Net income
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EPS
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

Announcement Date31/03/2231/03/2301/04/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-



0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-2,99
-2,90
-2.97%
-4,71
-3,90
-20.7%
-4,95
-5,30
6.54%
-5,53
-5,60
1.3%



-5,13
-5,10
-0.6%
-5,33
-5,60
4.87%
-4,06
-5,70
28.79%

-3,20


-3,40


-3,80


-4,30

Net income
Million USD
Released
Forecast
Spread












-4,82























EPS
USD
Released
Forecast
Spread












-264























Announcement Date31/03/2215/08/2214/11/2231/03/2315/05/2314/08/2314/11/2301/04/24----

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

  1. Stock Market
  2. Equities
  3. RNAZ Stock
  4. Calendar TransCode Therapeutics, Inc.